Pretreatment clinical and genetic factors predict early post-treatment mortality in fit AML patients following induction

Am J Hematol. 2021 Jul 1;96(7):E259-E262. doi: 10.1002/ajh.26188. Epub 2021 Apr 24.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Anthracyclines / administration & dosage
  • Anthracyclines / therapeutic use*
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use*
  • Cytarabine / administration & dosage
  • Cytarabine / therapeutic use*
  • Humans
  • Induction Chemotherapy*
  • Leukemia, Myeloid, Acute / diagnosis
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / mortality
  • Middle Aged
  • Prognosis
  • Treatment Outcome

Substances

  • Anthracyclines
  • Antineoplastic Agents
  • Cytarabine